GENinCode plc Acquires Abcodia Limited (ROCA Test)

September 28, 2022

Oxford-based GENinCode plc has acquired Cambridge-based Abcodia Limited and its Risk of Ovarian Cancer Algorithm (ROCA) test on an earnout basis with a maximum consideration of £1 million. The acquisition marks GENinCode’s first entry into oncology as it plans to accelerate ROCA revenues in the UK and pursue market entry in the United States and European Union.

Buyers
GENinCode plc
Targets
Abcodia Limited
Industry
Biotechnology
Location
Cambridgeshire, United Kingdom
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.